ARCHIVE

• SELF-MEDICATION NEWS IN BRIEF
  July 4, 2005

• MEDICAL DEVICE NEWS IN BRIEF
  July 4, 2005

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  July 4, 2005

• NEW PRODUCTS
  July 4, 2005

• R&D NEWS IN BRIEF
  July 4, 2005

• PEG-IFN + Ribavirin Effective against Hepatitis C: Society Meeting
  July 4, 2005

• Large-scale Clinical Trial to Assess Primary Preventive Effects of Aspirin
  July 4, 2005

• 7th Meeting of Japanese Society of Clinical Pharmacological Studies
  July 4, 2005

• BUSINESS NEWS IN BRIEF
  July 4, 2005

• JGPMA Formally Accepted as Observer at IGPA
  July 4, 2005

• JCR Pharmaceuticals Expects to Launch Generic EPO in 2009 or 2010
  July 4, 2005

• Blopress Is Japan's Top-selling Drug; Mevalotin Falls to 3rd
  July 4, 2005

• REGULATORY NEWS IN BRIEF
  July 4, 2005

• Generic Substitution Only Speculation at This Point: Mr Futagawa
  June 27, 2005

• REGULATORY NEWS IN BRIEF
  June 27, 2005

• Chugai to Establish New Strategic Marketing Unit in July
  June 27, 2005

• Healthnet to Enter Chinese Market with NDA Support Business
  June 27, 2005

• Mattson Jack Group to Strengthen Support in Field of Oncology
  June 27, 2005

• Takeda Leads Image Ranking among Clinicians: Nikkei BP Survey
  June 27, 2005

• BUSINESS NEWS IN BRIEF
  June 27, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 458
• 459
• 460
• 461
• 462
• 463
• 464
• 465
• 466
• …
• Next ›
• 最終 »